Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Clinical Lung Cancer
|
January 11, 2005
Bronchoalveolar carcinoma: current treatment and future trends
Janessa J Laskin
Future Oncology (London, England)
|
March 25, 2006
Adjuvant chemotherapy for non-small cell lung cancer: the new standard of care
Janessa J Laskin
Lung Cancer (Amsterdam, Netherlands)
|
July 18, 2003
The importance of the eicosanoid pathway in lung cancer
Janessa J Laskin, Alan B Sandler
Oncology (Williston Park, N.Y.)
|
January 24, 2006
First-line treatment for advanced non-small-cell lung cancer
Janessa J Laskin, Alan B Sandler
Clinical Advances in Hematology & Oncology : H&O
|
November 1, 2005
The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancer
Janessa J Laskin, Alan B Sandler
Cancer Investigation
|
October 1, 2005
State of the art in therapy for non-small cell lung cancer
Janessa J Laskin, Alan B Sandler
Seminars in Respiratory and Critical Care Medicine
|
August 10, 2005
Epidermal growth factor receptor inhibitors in lung cancer therapy
Janessa J Laskin, Alan B Sandler
Cancer Treatment Reviews
|
February 10, 2004
Epidermal growth factor receptor: a promising target in solid tumours
Janessa J Laskin, Alan B Sandler
Seminars in Oncology
|
July 1, 2005
Redefining bronchioloalveolar carcinoma
Janessa J Laskin, Alan B Sandler, David H Johnson
Leukemia & Lymphoma
|
November 3, 2005
Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis
Janessa J Laskin, Kerry J Savage, Nicholas Voss, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Clinical Lung Cancer
|
January 11, 2005
Bronchoalveolar carcinoma: current treatment and future trends
Janessa J Laskin
Future Oncology (London, England)
|
March 25, 2006
Adjuvant chemotherapy for non-small cell lung cancer: the new standard of care
Janessa J Laskin
Lung Cancer (Amsterdam, Netherlands)
|
July 18, 2003
The importance of the eicosanoid pathway in lung cancer
Janessa J Laskin, Alan B Sandler
Oncology (Williston Park, N.Y.)
|
January 24, 2006
First-line treatment for advanced non-small-cell lung cancer
Janessa J Laskin, Alan B Sandler
Clinical Advances in Hematology & Oncology : H&O
|
November 1, 2005
The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancer
Janessa J Laskin, Alan B Sandler
Cancer Investigation
|
October 1, 2005
State of the art in therapy for non-small cell lung cancer
Janessa J Laskin, Alan B Sandler
Seminars in Respiratory and Critical Care Medicine
|
August 10, 2005
Epidermal growth factor receptor inhibitors in lung cancer therapy
Janessa J Laskin, Alan B Sandler
Cancer Treatment Reviews
|
February 10, 2004
Epidermal growth factor receptor: a promising target in solid tumours
Janessa J Laskin, Alan B Sandler
Seminars in Oncology
|
July 1, 2005
Redefining bronchioloalveolar carcinoma
Janessa J Laskin, Alan B Sandler, David H Johnson
Leukemia & Lymphoma
|
November 3, 2005
Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis
Janessa J Laskin, Kerry J Savage, Nicholas Voss, et al.
Page
of 3